Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Allied Critical Metals Extends Santa Helena Zone with 6.0m of 1.02% WO3 at Borralha (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pluri Inc
PLUR
Healthcare
Biotechnology
Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical...
industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PLUR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 29, 2022 10:15am
Pluristem and Tnuva Ring the Closing Bell Full Video
https://www.nasdaq.com/events/pluristem-and-tnuva-ring-the-closing-bell
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 28, 2022 10:52am
Pluristem and Tnuva to Ring Nasdaq Closing Bell Today
Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI) (“Pluristem”), a leading biotechnology company, and Tnuva Group (“Tnuva Group” or “Tnuva”), Israel’s largest food producer, today announced
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 24, 2022 8:27am
Market reaction to results
$PSTI went up by 3% yesterady after the latest trail resluts. Possibly due to the option of a relevnt treatment in case of a nuclear distter looming in europe. The stock is now up by almost 40% since
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 23, 2022 10:22am
$PSTI Releases PLX-R18 Hematology Phase I Study Results
Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions Results show the potential in the use of PLX-R18 for
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 21, 2022 11:08am
https://www.investorsobserver.com/ take on $PSTI
https://www.investorsobserver.com/ take on $PSTI: Pluristem Therapeutics Inc. has risen 27.61% over the past month, closing at $1.62 on February 21. During this period of time, the stock fell as low
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 17, 2022 9:07am
$PSTI picked among the 10 Promising Biotech Penny Stocks
Pluristem Therapeutics Inc. (NASDAQ: PSTI) Pluristem is an Israeli pharmaceutical company specializing in the development of stem cell research and treatment. The company's solutions can be used
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 15, 2022 1:20pm
$PSTI future potential
On January 10th $PSTI announced their entrance to the cultured meat market via a collaboration with Tnuva (Israel's largest food producer) using Pluristem's advanced cell expansion technology,
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 13, 2022 11:24am
Pluristem Jerusalem Post article
“Our vision is to produce a series of companies, all of which will have their own management and financing but will have access to our technology platform and the knowledge we have accumulated over
...more
(76)
•••
lucaM1
X
Comment by
lucaM1
on Mar 10, 2022 9:56am
RE:$PSTI vastly outperforming the market in 2022.
Corection: In 2022 so far, $PSTI is outperforming the Nasdaq 100 by more than 50%. Very impressive from a stock that was trending down for a long time. New company expansion strategy really
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 10, 2022 9:47am
$PSTI vastly outperforming the market in 2022.
In 2022 so far, $PSTI is outpreforming the Nasdaq 100 by more than 50%. Very imlressive from a stock that was trending down for a long time. New comapny expansion stratefy really turining things
...more
(76)
•••
lucaM1
X
Post by
lucaM1
on Mar 08, 2022 9:41am
New CEO for the cultured meat subsidiary
Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture. An importent step in the new direction the comapny is going at. Hopefully deadlines
...more
(18)
•••
schrodingerscat
X
Post by
schrodingerscat
on Apr 14, 2020 12:58am
so far so good
ride this for a bit
(8)
•••
moosesdad
X
Post by
moosesdad
on Apr 13, 2020 7:20am
Premarket
Up 30% already
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Get into THE next Gold Play at ground level — Ripasso invites investors in at launch